270 related articles for article (PubMed ID: 22579007)
21. Efficacy and safety of a triple active sore throat lozenge in the treatment of patients with acute pharyngitis: Results of a multi-centre, randomised, placebo-controlled, double-blind, parallel-group trial (DoriPha).
Palm J; Fuchs K; Stammer H; Schumacher-Stimpfl A; Milde J;
Int J Clin Pract; 2018 Dec; 72(12):e13272. PubMed ID: 30329199
[TBL] [Abstract][Full Text] [Related]
22. Utility of the sore throat pain model in a multiple-dose assessment of the acute analgesic flurbiprofen: a randomized controlled study.
Schachtel B; Aspley S; Shephard A; Shea T; Smith G; Schachtel E
Trials; 2014 Jul; 15():263. PubMed ID: 24988909
[TBL] [Abstract][Full Text] [Related]
23. Relief of sore throat with the anti-inflammatory throat lozenge flurbiprofen 8.75 mg: a randomised, double-blind, placebo-controlled study of efficacy and safety.
Watson N; Nimmo WS; Christian J; Charlesworth A; Speight J; Miller K
Int J Clin Pract; 2000 Oct; 54(8):490-6. PubMed ID: 11198725
[TBL] [Abstract][Full Text] [Related]
24. A combination of topical antiseptics for the treatment of sore throat blocks voltage-gated neuronal sodium channels.
Foadi N; de Oliveira RC; Buchholz V; Stoetzer C; Wegner F; Pilawski I; Haeseler G; Leuwer M; Ahrens J
Naunyn Schmiedebergs Arch Pharmacol; 2014 Oct; 387(10):991-1000. PubMed ID: 25012093
[TBL] [Abstract][Full Text] [Related]
25. Onset of action of a lozenge containing flurbiprofen 8.75 mg: a randomized, double-blind, placebo-controlled trial with a new method for measuring onset of analgesic activity.
Schachtel B; Aspley S; Shephard A; Shea T; Smith G; Sanner K; Savino L; Rezuke J; Schachtel E
Pain; 2014 Feb; 155(2):422-428. PubMed ID: 24231654
[TBL] [Abstract][Full Text] [Related]
26. Bactericidal activity of hexylresorcinol lozenges against oropharyngeal organisms associated with acute sore throat.
Matthews D; Adegoke O; Shephard A
BMC Res Notes; 2020 Feb; 13(1):99. PubMed ID: 32093784
[TBL] [Abstract][Full Text] [Related]
27. Flurbiprofen microgranules for relief of sore throat: a randomised, double-blind trial.
Russo M; Bloch M; de Looze F; Morris C; Shephard A
Br J Gen Pract; 2013 Feb; 63(607):e149-55. PubMed ID: 23561694
[TBL] [Abstract][Full Text] [Related]
28. Randomised, double-blind, placebo-controlled studies on flurbiprofen 8.75 mg lozenges in patients with/without group A or C streptococcal throat infection, with an assessment of clinicians' prediction of 'strep throat'.
Shephard A; Smith G; Aspley S; Schachtel BP
Int J Clin Pract; 2015 Jan; 69(1):59-71. PubMed ID: 25296661
[TBL] [Abstract][Full Text] [Related]
29. Evidence of the Efficacy of Flurbiprofen 8.75 mg Lozenges for Patients Receiving Antibiotics for Laboratory-Confirmed Streptococcal Pharyngitis.
Schachtel B; Shephard A; Schachtel E; Shea T; Smith A; Tselenti E
Ear Nose Throat J; 2023 Dec; 102(12):NP609-NP617. PubMed ID: 34261371
[TBL] [Abstract][Full Text] [Related]
30. Flurbiprofen 8.75 mg lozenges for treating sore throat symptoms: a randomized, double-blind, placebo-controlled study.
Schachtel BP; Shephard A; Shea T; Sanner K; Savino L; Rezuke J; Schachtel E; Aspley S
Pain Manag; 2016 Nov; 6(6):519-529. PubMed ID: 27734772
[TBL] [Abstract][Full Text] [Related]
31. Demonstration of dose response of flurbiprofen lozenges with the sore throat pain model.
Schachtel BP; Homan HD; Gibb IA; Christian J
Clin Pharmacol Ther; 2002 May; 71(5):375-80. PubMed ID: 12011823
[TBL] [Abstract][Full Text] [Related]
32. Improvements in throat function and qualities of sore throat from locally applied flurbiprofen 8.75 mg in spray or lozenge format: findings from a randomized trial of patients with upper respiratory tract infection in the Russian Federation.
Burova N; Bychkova V; Shephard A
J Pain Res; 2018; 11():1045-1055. PubMed ID: 29910633
[TBL] [Abstract][Full Text] [Related]
33. Kikyo-to vs. Placebo on Sore Throat Associated with Acute Upper Respiratory Tract Infection: A Randomized Controlled Trial.
Ishimaru N; Kinami S; Shimokawa T; Kanzawa Y
Intern Med; 2019 Sep; 58(17):2459-2465. PubMed ID: 31178508
[TBL] [Abstract][Full Text] [Related]
34. Multidose flurbiprofen 8.75 mg lozenges in the treatment of sore throat: a randomised, double-blind, placebo-controlled study in UK general practice centres.
Blagden M; Christian J; Miller K; Charlesworth A
Int J Clin Pract; 2002 Mar; 56(2):95-100. PubMed ID: 11926713
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of a benzocaine lozenge in the treatment of uncomplicated sore throat.
Chrubasik S; Beime B; Magora F
Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):571-7. PubMed ID: 22015737
[TBL] [Abstract][Full Text] [Related]
36. Effects of acetylsalicylic acid on sore throat pain and other pain symptoms associated with acute upper respiratory tract infection.
Eccles R; Loose I; Jawad M; Nyman L
Pain Med; 2003 Jun; 4(2):118-24. PubMed ID: 12873261
[TBL] [Abstract][Full Text] [Related]
37. A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Ambroxol Hard-Boiled Lozenges in Patients with Acute Pharyngitis.
Sousa R; Lakha DR; Brette S; Hitier S
Pulm Ther; 2019 Dec; 5(2):201-211. PubMed ID: 32026411
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of ambroxol lozenges in the treatment of acute uncomplicated sore throat. EBM-based clinical documentation.
de Mey C; Peil H; Kölsch S; Bubeck J; Vix JM
Arzneimittelforschung; 2008; 58(11):557-68. PubMed ID: 19137906
[TBL] [Abstract][Full Text] [Related]
39. Onset of analgesia by a topically administered flurbiprofen lozenge: a randomised controlled trial using the double stopwatch method.
Schachtel B; Aspley S; Shephard A; Schachtel E; Lorton MB; Shea T
Br J Pain; 2018 Nov; 12(4):208-216. PubMed ID: 30349694
[TBL] [Abstract][Full Text] [Related]
40. [Symptomatic local therapy of the uncomplicated common cold. Multicenter controlled study of the effectiveness of an antiseptic lozenge].
Schneeweiss B; Graubaum HJ; Schneider B; Metzner C
Fortschr Med; 1998 May; 116(13):32-3. PubMed ID: 9630779
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
